Amount
$434,085,725
Recipient
Takeda Pharmaceuticals Australia Pty Ltd
Company — NSW
Selection Process
Direct Award
Period
31 Dec 2020 — 30 Dec 2027
Approved: 19 Jan 2021

Purpose

Procurement method: Limited tender

Program

National Blood Authority

National Blood Authority

Other Grants to Takeda Pharmaceuticals Australia Pty Ltd

GrantProgramAmountSelection
Supply of Advate and Adynovate Imported Plasma and … National Blood Authority $109,458,800 Direct Award
Imported Plasma and Recombinant Products National Blood Authority $30,209,374 Direct Award
Procurement of Imported Plasma and Recombinant Products (IPRP) … National Blood Authority $22,323,958 Open Competitive

Data Source

Source: AusTender
Category: UNSPSC 51000000
State: NSW | Postcode: 2000